cover
Article Per Year (5 Year)
All
Home Page
OAI Link
Editorial Team
Contact
Reviewer
Google Scholar
Contact Name
Raymond Pranata
Contact Email
raymond_pranata@hotmail.com
Phone
+6282112918892
Journal Mail Official
ijc@inaheart.org
Editorial Address
Editorial Office: Heart House, Jalan Katalia Raya No. 5, Kota Bambu Utara West Jakarta, 11430 - Indonesia Telephone: +62 21 5681149, Fax: +62 21 5684220 Email: ijc@inaheart.org
Location
Kota adm. jakarta barat,
Dki jakarta
INDONESIA
Indonesian Journal of Cardiology
Published by Indonesian Heart Association
ISSN : 28303105     EISSN : 29647304     DOI : -
Core Subject : Health,
Health Professions Medicine & Pharmacology
Indonesian Journal of Cardiology (IJC) is a peer-reviewed and open-access journal established by Indonesian Heart Association (IHA)/Perhimpunan Dokter Spesialis Kardiovaskular Indonesia (PERKI) [www.inaheart.org] on the year 1979. This journal is published to meet the needs of physicians and other health professionals for scientific articles in the cardiovascular field. All articles (research, case report, review article, and others) should be original and has never been published in any magazine/journal. Prior to publication, every manuscript will be subjected to double-blind review by peer-reviewers. We consider articles on all aspects of the cardiovascular system including clinical, translational, epidemiological, and basic studies. Subjects suitable for publication include but are not limited to the following fields: Acute Cardiovascular Care Arrhythmia / Cardiac Electrophysiology Cardiovascular Imaging Cardiovascular Pharmacotherapy Cardiovascular Public Health Policy Cardiovascular Rehabilitation Cardiovascular Research General Cardiology Heart Failure Hypertension Interventional Cardiology Pediatric Cardiology Preventive Cardiology Vascular Medicine
Arjuna Subject : Kedokteran - Cardiology and Cardiovascular Medicine
Articles 712 Documents
 47   48   49   50   51 
Temuan Gambaran CT Napkin Ring Sign Pada Pasien Asimtomatik Sony Hilal Wicaksono
Jurnal Kardiologi Indonesia Vol. 35, No. 3 Juli - September 2014
Publisher : The Indonesian Heart Association

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.30701/ijc.v35i3.429

Abstract

KasusSeorang laki-laki usia 56 tahun datang ke poliklinik rawat jalan untuk memeriksakan kesehatannya saat dalam keadaan tanpa keluhan atau asimtomatik. Keluhan selama ini tidak ada yang memiliki karakteristik angina atau sesak napas. Pasien memiliki riwayat penyakit jantung koroner dikeluarganya, yaitu dua orang kakak kandungnya (laki-laki) yang telah menjalani operasi jantung dan dipasang ring.Pasien pernah memeriksakan faktor risiko kardiovaskular dengan hasil terdapat peningkatan kadar kolesterol dalam darah yaitu LDL setinggi 150 mg/dL. Selain itu pasien juga dengan hipertensi grade 1 tekanan darah sistolik berkisar 140-150mmHg. Hasil EKG menunjukkan kesimpulan normal sinus ritme, tidak ditemukan kelainan pada setiap gelombang PQRST maupun setiap segmen PR dan ST.Karena gambaran EKG masih normal, dengan faktor risiko usia jenis kelamin dan riwayat keluarga serta dislipidemia, maka kami menganjurkan deteksi aterosklerosis kepada pasien dengan metode CT coronary angiography (CTCA).
Secretory Phospholipase A2 Tipe II (SPLA II) Pada Penyakit Kardiovaskuler Djanggan Sargowo
Jurnal Kardiologi Indonesia Vol. 35, No. 3 Juli - September 2014
Publisher : The Indonesian Heart Association

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.30701/ijc.v35i3.430

Abstract

Inflammatory reactions contribute to the pathogenesis of cardiovascular conditions such as atherosclerosis and ischemic damage in acute myocardial infarction (AMI). Among the mediators involved in inflammation are secretory phospholipase A2 group II (sPLA2-II) enzymes. Though some cells constitutively express Spla2-II, the synthesis by cells such as hepatocytes is typical for an acute-phase reactant. Recent literature suggest multiple roles for sPLA2-II in cardiovascular disease. In this review we discuss the role of sPLA2-II in included that sPLA2-II appears to be an inportant inflammatory mediator of cardiovascular disease.
Pedoman Terapi Memakai Alat Elektronik Kardiovaskular Implan (Aleka) Perhimpunan Dokter Spesialis Kardiovaskular Indonesia 2014 Dicky A Hanafy; Yoga Yuniadi; Sunu B Raharjo; Alexander E Tondas; Adhantoro Rahadian; Muhammad Yamin; Daniel Tanubudi; Beny Hartono; Muhammad Munawar
Jurnal Kardiologi Indonesia Vol. 35, No. 3 Juli - September 2014
Publisher : The Indonesian Heart Association

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.30701/ijc.v35i3.431

Abstract

PEDOMAN TERAPI MEMAKAI ALAT ELEKTRONIK KARDIOVASKULAR IMPLAN (ALEKA)Perkembangan dan kemajuan pada diagnostik dan terapi dalam tata laksana pasien dengan kelainan irama jantung merupakan dasar disusunnya pedoman terapi memakai alat elektronik kardiovaskular implan (Aleka) ini. Pedoman ini disusun oleh Perhimpunan Aritmia Indonesia - Indonesian Heart Rhythm Society (lnaHRS), sebuah kelompok kerja dari Perhimpunan Dokter Spesialis Kardiovaskular Indonesia (PERKI), berdasarkan pedoman terbaru yang dipublikasi oleh perhimpunan Eropa maupun Amerika Utara dan disesuaikan dengan keadaan lokal di Indonesia.Pedoman Aleka ini terdiri dari alat pacu jantung permanen (APJP), defibrilator kardiak implan (DKI) dan terapi resinkronisasi jantung (TRJ). Kumpulan rekomendasi ini memberi pedoman untuk penggunaan Aleka dengan tepat tetapi bukan sebagai pedoman untuk tata laksana aritmia secara umum.Bradikardia simtomatik menjadi indikasi implantasi APJP. Sebelum keputusan diambil untuk implantasi APJP, pertanyaan utama yang muncul adalah apakah simtom yang dialami pasien berhubungan dengan bradikardia, baik yang dicurigai maupun terdokumentasi. Ada kemungkinan bahwa kondisi yang terjadi bersifat sementara (akibat iskemia, efek samping obat, gangguan elektrolit, inflamasi, sepsis) dan dapat ditangani dengan pemacuan temporer serta dapat disembuhkan dengan mengobati penyebab yang mendasari. lndikasi implantasi APJP haruslah dievaluasi secara teliti dan dicari penyebab yang mendasari. lndikasi kelas I untuk implantasi APJP tidak dapat menyingkirkan pilihan tata laksana alternatif yang mungkin ada. Diagnosis banding termasuk penyebab kardiak maupun non-kardiak harus disingkirkan terlebih dahulu.Untuk terapi memakai Aleka, tidak hanya dibutuhkan pengetahuan gangguan irama jantung yang dalam namun juga pengetahuan teknik dasar. Pendekatan transvena telah mempermudah teknik bedah dan memudahkan tindakan implantasi sehingga dapat dilakukan oleh kardiolog. Hanya dengan memiliki pengertian yang mendalam mengenai keterkaitan antara fungsi dari pemacuan yang
Aplikasi Panduan ESC tentang Penyakit Arteri Koroner Stabil 2013 dan Revaskularisasi Miokard 2014: MRI Kardiak dengan Stres Adenosin dalam Diagnosis, Stratifikasi Risiko dan Strategi Penatalaksanaan Sony Hilal Wicaksono
Jurnal Kardiologi Indonesia Vol. 35, No. 3 Juli - September 2014
Publisher : The Indonesian Heart Association

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.30701/ijc.v35i3.432

Abstract

Ilustrasi KasusSeorang pasien perempuan usia 55 tahun memiliki keluhan angina tipikal/khas dan didiagnosis sebagai Angina PektorisStabil (APS), dengan factor risiko diabetes mellitus tipe 2, dislipidemia, hipertensi dan perokok aktif. Hasil elektrokardiogram (EKG) pasien ini menunjukkan irama sinus dengan laju QRS 71x/menit, gambaran gelombang qR di sadapan III, selain itu dalam batas normal.Pasien kemudian menjalani uji latih Jantung dengan treadmill. Uji treadmill dihentikan pada durasi 5 menit dan 46 detik karena kejadian penurunan tekanan darah yang drastis, dari 187/103 mmHg menjadi 117/97 mmHg. Tidak tampak perubahan gambaran elektrokardiogram.Karena hasil uji latih jantung dengan treadmill yang tidak konklusif, pada pasien direncanakan dilakukan pemeriksaan MRI kardiak dengan stress adenosine untuk mendeteksi iskemia pada kunjungan selanjutnya. Sementara pasien diberikan terapi medikamentosa yang optimal untuk penyakit arteri koroner stabil.
Intermittent Wide Qrs Complex During Sinus Rhythm Yoga Yuniadi
Jurnal Kardiologi Indonesia Vol. 35, No. 3 Juli - September 2014
Publisher : The Indonesian Heart Association

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.30701/ijc.v35i3.433

Abstract

Seorang pria 40 tahun datang ke poli Aritmia dengan keluhan palpitasi berulang. Pemeriksaan fisik dalam batas normal. Ekokardiografi didapatkan EF 56% dan angiografi menunjukkan arteri koroner normal. Rekaman EKG terlihat seperti gambar di bawah ini,Rekaman EKG menunjukkan gambaran bigemini yaitu selang-seling antara kompleks QRS sempit dan lebar. Perhatikan bahwa baik kompleks QRS sempit maupun lebar keduanya didahului oleh gelombang P. Yang menarik adalah (1) interval PR sangat pendek pada saat kompleks QRS lebar dan (2) interval PP kompleks QRS sempit ke QRS sempit(A) tidak merupakan dua
Penyakit Arteri Koroner: Pilih CABG atau PCI? Yoga Yuniadi
Jurnal Kardiologi Indonesia Vol. 36, No. 1 Januari - Maret 2015
Publisher : The Indonesian Heart Association

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.30701/ijc.v36i1.434

Abstract

Strategi revaskularisasi pada penyakit arteri koroner (PAK) terus menjadi bahan debat di kalangan kardiologi. Berbagai uji klinis yang telah dilakukan menunjukkan hasil yang bervariasi dan harus ditelaah secara detil karena persoalan strategi revaskularisasi menjadi masalah yang tidak sederhana tetapi harus memperhatikan subset pasien yang befvariasi untuk mendapatkan hasil yang terbaik. Prinsip dasar yang harus tetap dijaga oleh para kardiolog adalah keputusan medis harus berorientasi pada pasien. Patient first!Perbandingan secara tidak langsung antara bedah pintas arteri koroner (BPAK/CABG) dengan intervensi koroner perkutan (IKP/PCI) menunjukkan dengan CABG keperluan pengulangan revaskularisasi lebih sedikit. Masalah yang selalu dipertanyakan dalam membandingkan kedua teknik revaskularisasi itu adalah pengaruh perkembangan teknologi stent terhadap luaran pasien. Berbeda dengan teknik CABG relatif tidak banyak berubah yaitu terdiri dari teknik on- atau off-pump, sedangkan teknologi stent berkembang cepat dan mungkin akan memberikan luaran yang berbeda karena stent generasi terakhir dipercaya memiliki patency rate yang lebih baik. Teknologi stent berkembang dari bare-metal stent ke drug-eluting stent, kemudian drug eluting stent juga berevolusi mulai dari generasi pertama yang memakai obat sirolimus atau paclitaxel ke generasi kedua yang memakai obat everolimus atau zotarolimus. Demikian juga farmako-teknologi polymer yang berkembang ke arah polymer-free stent. Dalam hal platform stent dimulai dari stainless steel, cobalt chromium, platinum dan terakhir memakai polylactyic acid yang dapat diserap.
Model Prognostik Untuk Risiko Mortalitas Tiga Puluh Hari Pasca Transplantasi Jantung Dewasa Yanto S Tjang; Eva Suarthana; Reiner Korfer; Gero Tenderich; Diederick E Grobbee; Geert J.M.G. van der Heijden
Jurnal Kardiologi Indonesia Vol. 36, No. 1 Januari - Maret 2015
Publisher : The Indonesian Heart Association

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.30701/ijc.v36i1.435

Abstract

Objective: To develop a prognostic model for the thirty-day mortality risk after adult heart transplantation.Methods: In this report we developed a prediction model for the 30-day mortality risk after adult heart transplantation. Logistic regression analysis was used to develop the model in 1,262 adult patients undergoing primary heart transplantation. We evaluated the accuracy of the prediction model; the agreement between the predicted probability and the observed mortality (calibration); and the ability of the model to correctly discriminate between the discordant survival pairs (discrimination). The internal validity of the prediction model was evaluated using the bootstrapping procedures.Results: Recipients’ age and sex, pre-transplant diagnosis, transplant status, waiting time, cardiopulmonary bypass time, donors’ age and sex, donor-recipient mismatch for BMI and blood type were independent predictors for 30-day mortality risk after adult heart transplantation. The model showed a good calibration and reasonable discrimination (the corrected area under the receiver operating characteristic curve was 0.71). The internal validity of the prediction model was acceptable. For practical use, we converted the prediction model to score chart.Conclusion: The accuracy and the validity of the prediction model were acceptable. This easy-to-use instrument for predicting the 30-day mortality risk after adult heart transplantation would benefit decision-making by classifying recipients according to their mortality risk and allowing optimal allocation of a donor to a recipient for heart transplantation.
Hubungan Albuminuria dengan Silent Myocardial Ischemia dan Keterlambatan Heart Rate Recovery pada Subjek Pria Hipertensi Tanpa Diabetes Melitus Johan Winata; A. Lucia Panda; R. Abd Azis
Jurnal Kardiologi Indonesia Vol. 36, No. 1 Januari - Maret 2015
Publisher : The Indonesian Heart Association

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.30701/ijc.v36i1.436

Abstract

Background: Silent myocardial ischemia (SMI) defined asmyocardial ischemiawithout anginal pain. SMI is frequently found in diabetes due to autonomic neuropathy, but in hypertension the involvement of autonomic neuropathy is still not known. Heart rate recovery(HRR) has been known as manifestation of autonomic neuropathy.The simple measurement of HRR is potential as screening tools for autonomic neuropathy. Nevertheless, SMI and delayed HRR are known as independent predictors for cardiovasluar mortality, hence emphasize the importance for early diagnosis. In diabetes, albuminuria has been proven to be an independent predictor for SMI and delayed HRR, but in hypertensive patients without diabetes the correlation is still unclear.Objectives: This study is aimed to determine the incidence of SMI, delayed HRR, and albuminuria in hypertensive patients without diabetes, the correlation between albuminuria and SMI and delayed HRR.Methods: This is an observational study with cross-sectional approach. Fourty consecutive hypertensive without diabetes, history of chest pain, and known CAD. They underwent treadmill exercise testing with collection of spot urine before exercise to measure albumin urine to creatinine ratio (ACR). SMI and HRR to 3 minutes were then recorded.Results: SMI was diagnosed in 15% patients. The incidence of delayed HRR in the first, second and third minute after peak exercise were 60%,80%, and52.5% respectively. Albuminuria was significantly associated with SMI (OR 13.889 (1.423 – 135.544), p = 0.014). There were no signification correlation between albuminuria and delayed HRRConclusion: Albuminuria is a good predictor for SMI in hypertensive patients.
Peptida Polisakarida: Anti Inflamasi dan Anti Oksidan yang Menjanjikan pada Atherosklerosis Indra Prasetya; Ria Ashriyah; Ira Setyawati; Joko Hermawan; Widyo Mahargo; Yunita Leksono; Titin Andri W.; Teuku Heriansyah; Muhammad Aris W.; Djanggan Sargowo
Jurnal Kardiologi Indonesia Vol. 36, No. 1 Januari - Maret 2015
Publisher : The Indonesian Heart Association

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.30701/ijc.v36i1.437

Abstract

Background : Heart disease is the leading cause of death for both men and women, but heart disease is preventable and controllable. Ganoderma lucidum is widely used as traditional medicine for centuries particularly in China, Japan, and Korea. Previous study showed antioxidative activity of polysaccharide peptide (PsP) from Genoderma lucidum.Objective : This study was aimed to evaluate anti-inflammatory and antioxidant effect of polysaccharide peptide (PsP) from Ganoderma lucidum in atherosclerotic rats.Methods : The atherosclerotic rats were randomly divided into four groups (5 rats each group) : atherosclerotic model with high-fat diet, low dose PsP treated group (50 mg/kgBW), medium dose PsP treated group (150 mg/kgBW), high dose PsP treated group (300 mg/kgBW), with normal mice used as a control group. Parameters measured were the level of MDA, SOD, IL - 6 , IL - 10, hsCRP, TNF - ?, lipid profile and foam cell.Results : After PsP therapy for 5 weeks, the levels of MDA (p=0.01), hsCRP (p=0.018) in rats model of atherosclerosis decrease significantly. PsSP can reduce levels of IL - 6 (p=0.933) and increase levels of SOD (p=0.28) descriptively at PsP doses 150 mg/kgBW. While the levels of TNF-? (p=0.894) and IL-10 (p=0.98) was not affected by administration of PsP. PsP improve the lipid profile by increasing HDL (p=0.002) and lowering total cholesterol (p=0.04). The formation of foam cells (p=0.024) as a marker of atherogenesis significantly decreased by administration of PsP .Conclusion : PSP can be useful to reduce inflammatory processes and oxidative stress to prevent the process of atherogenesis.
Myxoma Atrium Kiri dengan Regurgitasi Trikuspid: Patofisiologi, Diagnosis dan Tata Laksana Prima Almazini; Bambang Budi Siswanto; Nani Hersunarti; Rarsari Soerarso; Amiliana M Soesanto
Jurnal Kardiologi Indonesia Vol. 36, No. 1 Januari - Maret 2015
Publisher : The Indonesian Heart Association

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.30701/ijc.v36i1.438

Abstract

Cardiac myxomas are the most common primary cardiac tumors. Myxoma are more common in women. Clinical manifestations can mimic many cardiac and noncardiac conditions. Transthoracic echocardiography (TTE) is the gold standard method in the diagnosis of cardiac myxoma. The management of cardiac myxoma are medical therapy for the treatment of associated conditions and surgical removal as the definitive treatment.

Page 49 of 72 | Total Record : 712

 47   48   49   50   51 

Filter by Year

2002 2025


Reset
Filter By Issues
All Issue Vol 46 No 4 (2025): October - December, 2025 Vol 46 No 3 (2025): July - September, 2025 Vol 46 No 2 (2025): April - June, 2025 Vol 46 No 1 (2025): January - March, 2025 Vol 45 No Suppl_A (2024): Vol 45 No Suppl_A (2024): Abstracts of the 6th Indonesian Intensive & Acut Vol 45 No 4 (2024): Online First - Indonesian Journal of Cardiology April-June 2021 Vol 45 No 3 (2024): July - September, 2024 Vol 45 No 2 (2024): April - June, 2024 Vol 45 No 1 (2024): January - March, 2024 Vol 45 No Suppl_C (2024): Abstracts of the 33rd Annual Scientific Meeting of the Indonesian Heart As Vol 45 No Suppl_B (2024): Abstracts of the 11th Annual Scientific Meeting of the Indonesian Heart Rh Vol 44 No 4 (2023): Indonesian Journal of Cardiology: October - December 2023 Vol 44 No 3 (2023): Indonesian Journal of Cardiology: July - September 2023 Vol 44 No 2 (2023): Indonesian Journal of Cardiology: April - June 2023 Vol 44 No 1 (2023): Indonesian Journal of Cardiology: January - March 2023 Vol 44 No Suppl_A (2023): Abstracts of the 32nd Annual Scientific Meeting of the Indonesian Heart As Vol 44 No Suppl_B (2023): Abstracts of the 10th Annual Scientific Meeting of the Indonesian Heart Rh Vol 43 No 4 (2022): Indonesian Journal of Cardiology: October - December 2022 Vol 43 No 3 (2022): Indonesian Journal of Cardiology: July - September 2022 Vol 43 No 2 (2022): Indonesian Journal of Cardiology: April - June 2022 Vol 43 No Suppl_B (2022): Abstracts of the 6th InaPrevent (2022) Vol 43 No 1 (2022): Indonesian Journal of Cardiology: January - March 2022 Vol 43 No Suppl_C (2022): Abstracts of the 31st Annual Scientific Meeting of the Indonesian Heart As Vol 43 No Suppl_D (2022): Abstracts of the 9th Annual Scientific Meeting of the Indonesian Heart Rhy Vol 43 No Supplement (2022): Abstracts of the 5th Indonesian Intensive and Acute Cardiovascular Care Vol 42 No 4 (2021): Indonesian Journal of Cardiology: October - December 2021 Vol 42 No 3 (2021): Indonesian Journal of Cardiology: July - September 2021 Vol 42 No 2 (2021): Indonesian Journal of Cardiology: April - June 2021 Vol 42 No 1 (2021): Indonesian Journal of Cardiology: January - March 2021 Vol 42 No Supplement (2021): Abstracts of the 5th InaPrevent in Conjunction with the 1st InTension S Vol 42 No Supplement (2021): Abstracts of the 13th Indonesian Society of Interventional Cardiology A Vol 42 No Supplement (2021): Abstracts of the 8th Annual Scientific Meeting of the Indonesian Heart Vol 41 No 4 (2020): Indonesian Journal of Cardiology: October - December 2020 Vol 41 No 3 (2020): Indonesian Journal of Cardiology: July - September 2020 Vol 41 No 2 (2020): Indonesian Journal of Cardiology: April - June 2020 Vol 41 No 1 (2020): Indonesian Journal of Cardiology: Januari - Maret 2020 Vol 41 No Suppl_A (2020): Abstracts of the 29th Annual Scientific Meeting of the Indonesian Heart As Vol 41 No Suppl_B (2020): Abstracts of the 12th Indonesian Society of Interventional Cardiology Annu Vol 40 No 4 (2019): Indonesian Journal of Cardiology: October-December 2019 Vol 40 No 3 (2019): Indonesian Journal of Cardiology: July-September 2019 Vol 40 No 2 (2019): Indonesian Journal of Cardiology: April-June 2019 Vol 40 No 1 (2019): Indonesian Journal of Cardiology: January-March 2019 Vol 39 No 4 (2018): Indonesian Journal of Cardiology: October-December 2018 Vol 39 No 3 (2018): Indonesian Journal of Cardiology: July-September 2018 Vol 39 No 2 (2018): Indonesian Journal of Cardiology: April-June 2018 Vol 39 No 1 (2018): January - March 2018 Vol 39 No 1 (2018): January - March 2018 Vol 39 No Suppl_A (2018): Indonesian Journal of Cardiology Supplement_A Vol 39 No Suppl_B (2018): Indonesian Journal of Cardiology Supplement_B Vol 39 No Suppl_B (2018): Indonesian Journal of Cardiology Supplement_B Vol 39 No Suppl_A (2018): Indonesian Journal of Cardiology Supplement_A Vol 38 No 4 (2017): October - December 2017 Vol 38 No 4 (2017): October - December 2017 Vol 38 No 3 (2017): July - September 2017 Vol 38 No 3 (2017): July - September 2017 Vol. 38, No. 2 April-June 2017 Vol. 38, No. 2 April-June 2017 Vol. 38, No. 1 Januari-Maret 2017 Vol. 37, No. 4 Oktober - Desember 2016 Vol. 37, No. 3 Juli - September 2016 Vol. 37, No. 2 April - Juni 2016 Vol. 37, No. 1 Januari - Maret 2016 Vol. 36, No. 4 Oktober - Desember 2015 Vol. 36, No. 3 Juli - September 2015 Vol. 36, No. 2 April - Juni 2015 Vol. 36, No. 1 Januari - Maret 2015 Vol. 35, No. 4 Oktober - Desember 2014 Vol. 35, No. 3 Juli - September 2014 Vol. 35, No. 2 April - Juni 2014 Vol. 35, No. 1 Januari - Maret 2014 Vol. 34, No. 4 Oktober - Desember 2013 Vol. 34, No. 3 Juli - September 2013 Vol. 34, No. 2 April - Juni 2013 Vol. 34, No. 1 Januari - Maret 2013 Vol. 33, No. 4 Oktober - Desember 2012 Vol. 33, No. 3 Juli - September 2012 Vol. 33, No. 2 April - Juni 2012 Vol. 33, No. 1 Januari - Maret 2012 Vol. 32, No. 4 Oktober - Desember 2011 Vol. 32, No. 3 Juli - September 2011 Vol. 32, No. 2 April - Juni 2011 Vol. 32, No. 1 Januari - Maret 2011 Vol. 31, No. 3 September - Desember 2010 Vol. 31, No. 2 Mei - Agustus 2010 Vol. 31, No. 1 Januari - April 2010 Vol. 30, No. 3 September - Desember 2009 Vol. 30, No. 2 Mei - Agustus 2009 Vol. 30, No. 1 Januari - April 2009 Vol. 29, No. 3 September - Desember 2008 Vol. 29, No. 2 Mei - Agustus 2008 Vol. 29, No. 1 Januari - April 2008 Vol. 28, No. 6 November 2007 Vol. 28, No. 5 September 2007 Vol. 28, No. 4 Juli 2007 Vol. 28, No. 3 Mei 2007 Vol. 28, No. 2 Maret 2007 Vol. 28, No. 1 Januari 2007 Vol. 26, No. 1 Januari - Maret 2002 More Issue